Pharmaceutical Litigation
If you are like countless Americans, you depend on
prescription or over-the-counter drugs to improve your
health. As a consumer, you expect that companies have
taken every step to ensure that these drugs will be
safe. Unfortunately, every year thousands of people
experience harmful side effects due to defective drugs
that result in serious injury and even death.
Some of the side effects that have been linked to
defective drugs are:
- Birth defects
- Heart attack
- Heart palpitations
- Insomnia
- Loss of memory
- Stomach aches
- Stroke
In the United States, a drug is not released into the
marketplace until it is approved by a federal agency
known as the Food and Drug Administration (FDA). Due to
various issues ranging from funding to manufacturer
pressure, the FDA has been criticized for releasing
inadequately tested drugs. If a drug is shown to do more
harm than good, warnings on its use may be issued or it
may be recalled by the FDA.
>For answers to common questions about prescription
drugs and injuries, please review our
Prescription
Injury FAQs.
Recently, warnings have been announced about several
popular drugs including:
- Anti-anxiety drugs such as Paxil
- Anti-osteoporosis drugs such as
Fosamax
- Anti-psychotic drugs such as Zyprexa
- Birth control patches such as
Ortho Evra
- Children’s ADHD drugs such as
Ritalin
- Heart surgery drugs such as Trasylol
- Weight-loss drugs such as Fen-Phen
Other well-known drugs such as Bextra,
Celebrex, and
Vioxx have been removed from the marketplace through
recalls. Unfortunately, most recalls do not occur until
after millions of patients have taken the defective
drug. Typically, neither the patient nor the patient’s
doctor knows of the drug’s dangers. In such situations,
the drug manufacturer can be held responsible for any
injuries because manufacturers must exercise reasonable
care in the design and manufacture of their product.
Regrettably, some defective drug claims are never filed
because the harm done to the patient is not recognized
as having been caused by the drug.
If you or a loved one has been prescribed a defective
drug, you may be entitled to recover monetary
compensation. Don’t wait to talk to us as there are
mandatory time limits in which claims can be filed
against defective drug manufacturers. The Kansas City,
Missouri law firm of Peterson & Associates has
successfully resolved thousands of cases involving
pharmaceutical and medical device manufactures. Let us
put our experience and expertise to work for you.
Contact the law offices of Peterson & Associates for
a free consultation by calling 816-LAW-FIRM, or by
clicking here to submit
online.
For more information:
Prescription
Injury FAQs
Pharmaceutical Legal Glossary
Pharmaceutical Litigation Evaluation
FDA News Alerts
Lantus (insulin glargine)
FDA reviewing safety data regarding possible risk for cancer in patient with diabetes.
Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics)
FDA requires new Boxed Warnings and patient Medication Guides highlighting the risk of serious neuropsychiatric symptoms
Nestle Toll House Prepackaged, Refrigerated Cookie Dough
FDA and the CDC are warning consumers not to eat any varieties of prepackaged Nestle Toll House refrigerated cookie dough due to the risk of contamination with E. coli O157:H7 (a bacterium that causes food borne illness). Since March 2009 there have been 66 reports of illness across 28 states. Twenty-five persons were hospitalized; 7 with a severe complication called Hemolytic Uremic Syndrome. No one has died.E. coli O157:H7 causes abdominal cramping, vomiting and a diarrheal illness,
often with bloody stools. Most healthy adults can recover completely within a week. Young children and the elderly are at highest risk for developing HUS,which can lead to serious kidney damage and even death.
Stamina
FDA and Hi-Tech Pharmaceuticals notified patients and healthcare professionals of a nationwide recall of all product sold under the name Stamina-Rx. Hi-Tech was notified by the FDA that the lab analysis of Stamina-Rx samples found that the product contained the undeclared ingredient - benzamidenafil - a Phosphodiesterase Type 5 inhibitor.
Cefepime (marketed as Maxipime) Update of Ongoing Safety Review
FDA finished its analysis of a possible risk of higher death with cefepime and has determined that the data do not indicate a higher rate of death in cefepime-treated patients.
|
